Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T11:35:44.771Z.
Calculation as of: 2026-10-06T11:35:44.771Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 58a2fa14633c50703c8ff5f7fcb702de1515a66dae0cc773e6a723eda01f3aaa
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.89B
Free Cash Flow Yield
10.44%
TTM Avg
9.69%
3Y Avg
6.96%
5Y Avg
5.58%
Market Cap
$13.19B
Free Cash Flow Yield
0.81%
TTM Avg
2.04%
3Y Avg
2.88%
5Y Avg
3.84%
Market Cap
$12.52B
Free Cash Flow Yield
5.41%
TTM Avg
4.28%
3Y Avg
4.09%
5Y Avg
3.89%
Market Cap
$12.49B
Free Cash Flow Yield
1.73%
TTM Avg
1.48%
3Y Avg
1.29%
5Y Avg
1.22%
Market Cap
$12.17B
Free Cash Flow Yield
3.31%
TTM Avg
3.33%
3Y Avg
2.65%
5Y Avg
2.65%
Market Cap
$12.00B
Free Cash Flow Yield
3.44%
TTM Avg
3.88%
3Y Avg
3.30%
5Y Avg
3.43%
Market Cap
$14.16B
Free Cash Flow Yield
2.73%
TTM Avg
0.77%
3Y Avg
0.77%
5Y Avg
0.77%
Market Cap
$11.47B
Free Cash Flow Yield
14.03%
TTM Avg
12.24%
3Y Avg
11.92%
5Y Avg
12.30%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | N/A | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 10.44% | 9.69% | 6.96% | 5.58% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.81% | 2.04% | 2.88% | 3.84% |
| Baxter International Inc. (BAX)vs › | $12.52B | 5.41% | 4.28% | 4.09% | 3.89% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 1.73% | 1.48% | 1.29% | 1.22% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 3.31% | 3.33% | 2.65% | 2.65% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 3.44% | 3.88% | 3.30% | 3.43% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 2.73% | 0.77% | 0.77% | 0.77% |
| DaVita Inc. (DVA)vs › | $11.47B | 14.03% | 12.24% | 11.92% | 12.30% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 2.32% | 2.56% | 2.37% | 2.19% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
